Global 3D Printing in Healthcare Market Size, Share, Growth & Trends Analysis Report by Component (System, Materials, Services), by Technology (Droplet Deposition, Photopolymerization, Laser Beam Melting, Electronic Beam Melting (EBM), Laminated Object Manufacturing, Others) by Application (External Wearable Devices, Clinical Study Devices, Implants, Tissue Engineering), by End User (Medical & Surgical Centers, Pharmaceutical & Biotechnology Companies, Academic Institutions), Regional Outlook, Growth Potential and Segments Forecast 2024-2030

Loading...

Budget constraints? Get in touch with us for special pricing

Buying Options

Original price was: $6,000.00.Current price is: $5,100.00.
Original price was: $5,000.00.Current price is: $4,500.00.
Original price was: $4,000.00.Current price is: $3,800.00.
Loading...

Description

The Global 3D Printing in Healthcare Market size was USD 1448.10 billion in 2022 and it is expected to grow to USD 6052.50 billion in 2030 with a CAGR of 19.85 % in the 2023-2030 period.

Global 3D Printing in Healthcare Market: Overview

The process of 3D printing includes the manufacturing of objects that are dimensionally solid which is mainly used in the healthcare sector and is known in the name of additive manufacturing. Additive processes are put into use with a view to achieving 3D-printed objects. Multiple layers are laid on each other in a successive manner to create an object while using the additive process for manufacturing. The layouts present themselves as very thin sliced layers in the form of a cross-section obtained from the object. Customized medical devices and equipment that are utilized in the healthcare sector are manufactured with the help of this process. The rapidly increasing demand for personalized healthcare facilities which are provided by the use of customized medical equipment according to the requirement of the patient has emerged as a major growth factor for 3D printing technology.

Global 3D Printing in Healthcare Market: Covid-19 Impact

The outbreak of the pandemic had a considerable impact on the growth of 3D printing in the healthcare market. The implication of the global lockdown restricted mode imposed by the government hampered the growth of the market to a great extent. This step was taken to prevent the further spread of infection and control the rate of mortality. The healthcare sector suffered a tremendous loss during this period When the hospitals were given strict guidelines to entertain only emergency and unavoidable cases with a view to preventing the chances of cross-infection between the infected patients and the medical staff. The huge number of patients who were infected during the course of the pandemic hampered the growth of the market to a great extent.

Global 3D Printing in Healthcare Market: Growth Drivers

  • Growing public-private funding for 3D printing activities:

    There has been a significant increase in public-private funding to support various initiatives in the 3D printing industry in recent years which is further driving the growth of the healthcare 3D printing market.

                                          

 

 

  • Technological developments:

    3D printing provides numerous technological advancements over traditional manufacturing processes, and broadening its range of applications across industries will further accelerate the demand for the healthcare 3D printing market.

  • Growing demand for patient-specific implants:

    Increasing demand for patient-specific implants in orthopedic, dental, and other surgical procedures will further positively influence the growth rate of the healthcare 3D printing market.

Global 3D Printing in Healthcare Market: Restraining Factors

  • Limited Adoption by Healthcare Facilities:

    Despite the potential benefits of 3D printing in healthcare, the adoption of this technology in many healthcare facilities remained limited. Resistance to change, lack of awareness, and concerns about costs and training may hinder widespread implementation.

  • High Initial Investment:

    The capital cost of acquiring 3D printing equipment and setting up a 3D printing facility can be significant, especially for smaller healthcare institutions and resource-constrained settings. This high initial investment may discourage some healthcare providers from adopting 3D printing technology.

  • Regulatory and Legal Challenges:

    The regulatory landscape for 3D printing in healthcare is still evolving, and navigating the complex regulatory processes can be a challenge for manufacturers. Ensuring compliance with quality and safety standards, as well as obtaining necessary approvals, may pose barriers to market growth.

Global 3D Printing in Healthcare Market:  Opportunity Factors

  • Customization and Personalization:

    3D printing enables the production of highly personalized medical devices, prosthetics, and implants based on individual patient needs and anatomical data. This customization can lead to improved treatment outcomes and patient satisfaction.

  • Rapid Prototyping and Iterative Design:

    3D printing allows for rapid prototyping of medical devices and models, facilitating iterative design processes. Manufacturers can quickly test and refine their designs, reducing development time and improving product quality.

  • Bioprinting and Tissue Engineering:

    Advancements in bioprinting technology present opportunities for tissue engineering and regenerative medicine. 3D-printed tissues and organs have the potential to revolutionize transplantation and therapeutic applications.

  • Surgical Planning and Training:

    3D-printed anatomical models can be used for surgical planning and training purposes. Surgeons can practice complex procedures on lifelike models, enhancing surgical precision and reducing the risk of complications.

Global 3D Printing in Healthcare Market: Challenges

  • Material Biocompatibility and Safety Concerns:

    3D printing materials used in healthcare applications must be biocompatible and meet strict safety standards. Ensuring the safety and biocompatibility of 3D-printed medical devices and implants is crucial for regulatory approval and patient acceptance.

  • Intellectual Property and Counterfeiting:

    As 3D printing becomes more accessible, protecting intellectual property rights for medical device designs becomes more difficult. Counterfeiting and unauthorized production of medical devices can lead to safety issues and revenue losses for original manufacturers.

  • Skill and Expertise Gap:

    Operating and maintaining 3D printing equipment requires specialized knowledge and skills. The shortage of skilled personnel in this field may limit the scale and effectiveness of 3D printing adoption in healthcare.

Global 3D Printing in Healthcare Market: Segmentation

  • Based on Components: On the basis of components, the market is segmented into, Systems, Materials, and Services. The segment of the system has emerged as the largest market due to its increasing demand in the healthcare sector. The rapid advancements in the field of technology which have been experienced in the form of full-color 3D printing and multi-material use have boosted the demand for advanced technologies in the market.
  • Based on Technology: On the basis of technology, the market is segmented into, Droplet Deposition, Photopolymerization, Laser Beam Melting, Electronic Beam Melting (EBM), Laminated Object Manufacturing, and Others. The segment of droplet deposition has emerged as the fastest-growing market as far as technology is concerned. The increasing demand for droplet deposition techniques has boosted the size of the market to a great extent.
  • Based on Application: On the basis of the Application, the market is divided into, External Wearable Devices, Clinical Study Devices, Implants, and Tissue Engineering. the segment of external wearable devices has emerged as a major market due to its increasing demand among potential consumers. The rules and regulations pertaining to 3D printers have been relaxed considerably which has emerged as a major opportunity for the market.
  • Based on End User: On the basis of End User, the market is segmented into, Medical & Surgical Centers, Pharmaceutical & Biotechnology Companies, and Academic Institutions. The segment of surgical and medical centers has emerged as the largest market and it’s foreseen to maintain its position during the future as well. The huge number of people who opt for surgical procedures has boosted the demand for modern technology in this sector.
  • Based on Region: On the basis of the region, the market is segmented into five key geographical regions namely – North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Global 3D Printing in Healthcare Market: Regional Insights

The global 3D Printing in Healthcare market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Each region has its own market dynamics and demand drivers, which can influence the revenue contribution and growth opportunities in 3D Printing in the Healthcare market. North America has emerged as the largest market for this advanced technology and is foreseen to maintain its position during the forecast period. The rapid advancements in the healthcare sector brought about by the government have boosted the size of the market to a great extent. Increasing awareness among the people regarding the available options has also helped the market to record considerable revenue over the period of time. The huge number of operative procedures that are carried out in this region has also emerged as a major growth factor for the printing in the healthcare market.

Global 3D Printing in Healthcare Market: Competitive Analysis

Formlabs Inc., General Electric, 3D Systems Corporation, Exone Company, Materialise NV, Oxferd Performance Materials Inc., SLM Solutions Group AG, Organovo Holdings Inc., Proto Labs, Stratasys Ltd.

Global 3D Printing in Healthcare Market: Recent Developments

  • November 2022: Evonik launched three new INFINAM photopolymers for industrial 3D applications, expanding their photo-resins product line. The product line is intended for use in common UV-curing 3D printing processes. The INFINAM RG 2000 L is a photo resin for the eyewear industry. 
  • June 2022: Belgian contract manufacturer Amnovis and medical device service provider BAAT Medical teamed up to offer an innovative and rapid turnaround process for 3D-printed medical devices. Both Amnovis and BAAT Medical have experience in 3D printing medical devices for a range of certified end-use applications.

Table of Content

1. Introduction
1.1. Market Definition
1.2. Market Scope
2. Research Methodology
2.1. Primary Research
2.2. Secondary Sources
2.3. Assumptions & Exclusions
3. Market Overview
3.1. Market Overview
3.2. Research Report Segmentation & Scope
3.3. Value Chain Analysis
3.4. Key Market Trend Analysis
3.4.1. Market Drivers
3.4.2. Market Restraint/Challenges
3.4.3. Market Opportunities
3.5. Porter’s Five Forces Analysis
3.6. Potential Venture Avenues
3.7. Market Share Analysis
3.8. Regulatory Framework
3.9. Marketing Strategy
3.10. Key Winning Strategy
3.11. Consumer Behavior Analysis
4. Product Overview
4.1. Introduction
4.2. Market Size & Forecast, 2020 to 2029
4.2.1. By Technology Type
4.2.1.1. Stereolithography (SLA)
4.2.1.2. Selective Laser Sintering (SLS)
4.2.1.3. Fused Deposition Modeling (FDM)
4.2.1.4. Digital Light Processing (DLP)
4.2.1.5. Bioprinting
5. Application Overview
5.1. Introduction
5.2. Market Size & Forecast, 2020 to 2029
5.2.1. Application
5.2.1.1. Medical Implants
5.2.1.2. Prosthetics and Orthotics
5.2.1.3. Surgical Instruments and Guides
5.2.1.4. Dental Applications
5.2.1.5. Pharmaceuticals
5.2.1.6. Tissue Engineering and Regenerative Medicine
6. End Users Overview
6.1. Introduction
6.2. Market Size & Forecast, 2020 to 2029
6.2.1. Hospitals and Clinics
6.2.2. Dental Laboratories
6.2.3. Medical Device Companies
6.2.4. Academic and Research Institutions
7. Regional Overview
7.1. Introduction
7.2. Market Size & Forecast, 2020 to 2029
7.2.1. Americas
7.2.1.1. North America
7.2.1.1.1. U.S.
7.2.1.1.2. Canada
7.2.1.2. South America
7.2.2. Europe
7.2.2.1. Western Europe
7.2.2.1.1. Germany
7.2.2.1.2. France
7.2.2.1.3. U.K.
7.2.2.1.4. Italy
7.2.2.1.5. Spain
7.2.2.1.6. Rest Of Western Europe
7.2.2.2. Eastern Europe
7.2.3. Asia Pacific
7.2.3.1. China
7.2.3.2. Australia
7.2.3.3. Japan
7.2.3.4. India
7.2.3.5. Republic of Korea
7.2.3.6. Rest of Asia Pacific
7.2.4. The Middle East & Africa
7.2.4.1. The Middle East
7.2.4.1.1. UAE
7.2.4.1.2. Saudi Arabia
7.2.4.1.3. Kuwait
7.2.4.1.4. Qatar
7.2.4.1.5. Rest of the Middle East
7.2.4.2. Africa
8. Manufacturer/ Vendor Profile
8.1. The following attributes will be considered while profiling key manufacturers in this industry:
8.1.1. Company Overview
8.1.2. Financial Synopsis
8.1.3. Recent Developments
8.1.4. R&D Investments (if any)
8.1.5. Strategy Overview (Analyst Perspective)
8.1.6. Product Portfolio
8.2. Companies Profiled
8.2.1. 3D Systems Corporation
8.2.2. Stratasys Ltd.
8.2.3. Materialise NV
8.2.4. EnvisionTEC
8.2.5. EOS GmbH
8.2.6. Renishaw plc
8.2.7. SLM Solutions Group AG
8.2.8. Formlabs Inc.
8.2.9. Carbon, Inc.
8.2.10. HP Inc.

Frequently Asked Questions (FAQ):

  • 1. Which is the leading segment in the Global 3D Printing in Healthcare Market?

    - Among Components, the system segment contributes a Major share of the Global 3D Printing in the Healthcare Market.
  • 2. What are the key factors driving Global 3D Printing in Healthcare Market?

    - There has been a significant increase in public-private funding to support various initiatives in the 3D printing industry in recent years which is further driving the growth of the healthcare 3D printing market.
  • 3. Which region will contribute notably towards the Global 3D Printing in Healthcare Market growth?

    - North America region to contribute the major share towards the market growth because it is the fastest growing region.
  • 4. What are the key players in the Global 3D Printing in Healthcare Market?

    - Formlabs Inc., General Electric, 3D Systems Corporation, Exone Company, Materialise NV, Oxferd Performance Materials, Inc., SLM Solutions Group AG, Organovo Holdings, Inc., Proto Labs, Stratasys Ltd

Buying Options

Original price was: $6,000.00.Current price is: $5,100.00.
Original price was: $5,000.00.Current price is: $4,500.00.
Original price was: $4,000.00.Current price is: $3,800.00.